Mitral geometry on the Mechanism of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy is organized by American Society of Echocardiography (ASE).
Release Date: August 1, 2024
Expiration Date: August 1, 2025
Description:
Hypertrophic cardiomyopathy (HCM) is a complex inherited cardiomyopathy due to sarcomere protein gene mutations, with an estimated prevalence ranging from 1:500 to as high as 1:200.1 The pathologic manifestations of symptomatic HCM are often attributable to left ventricular outflow tract obstruction (LVOTO), left ventricular (LV) diastolic dysfunction, and mitral regurgitation (MR). Patients with LVOTO may be at increased risk of developing arrhythmias, stroke, heart failure, or sudden cardiac death.2,3 Extended transaortic septal myectomy is the gold standard for the treatment of patients with symptomatic hypertrophic obstructive cardiomyopathy (HOCM).4 Given that LVOTO is a complex entity arising from various phenotypes of LV hypertrophy (LVH) and mitral valve (MV) apparatus abnormalities, understanding the mechanisms of LVOTO plays a crucial role in surgical management and clinical care.
In patients with obstructive HCM without overt LVH, redundant MV leaflets, aberrant muscle bundles or chordal attachments, and hypermobile bifid papillary muscle are often associated with dynamic LVOTO and may require additional surgical intervention.5, 6, 7 However, the impact of MV geometry on the mechanism of LVOTO in HCM has not been fully explored. The aortomitral angle is the angle between the mitral annular plane and the aortic annular plane and is a known predictor of the likelihood of MV systolic anterior motion (SAM) after MV repair.8 To our knowledge, this is the first study to consider the assessment of MV geometry, rather than septal hypertrophy, as a more important component in LVOTO. The primary objective of the present study is to determine which MV geometry is an independent predictor of obstruction in HCM.
Learning Objectives:
Accreditation Statement:
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Society of Echocardiography designates this activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®. Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved